Your browser doesn't support javascript.
loading
Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second-line lenalidomide + dexamethasone induction in multiple myeloma.
Lund, Johan; Gruber, Astrid; Lauri, Birgitta; Duru, Adil Doganay; Blimark, Cecilie; Swedin, Agneta; Hansson, Markus; Forsberg, Karin; Ahlberg, Lucia; Carlsson, Conny; Waage, Anders; Gimsing, Peter; Vangsted, Annette Juul; Frølund, Ulf; Holmberg, Erik; Gahrton, Gösta; Alici, Evren; Hardling, Mats; Mellqvist, Ulf-Henrik; Nahi, Hareth.
Afiliação
  • Lund J; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Gruber A; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Lauri B; Department of Internal Medicine, Sunderby Hospital, Luleå, Sweden.
  • Duru AD; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Blimark C; Nova Southeastern University (NSU), Fort Lauderdale, Florida.
  • Swedin A; Department of Hematology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Hansson M; Department of Hematology, Skåne University Hospital, Lund, Sweden.
  • Forsberg K; Department of Hematology, Skåne University Hospital, Lund, Sweden.
  • Ahlberg L; Department of Hematology, Norrland University Hospital, Umeå, Sweden.
  • Carlsson C; Department of Hematology, University Hospital of Linköping, Linköping, Sweden.
  • Waage A; Department of Internal Medicine, Hallands Hospital, Halmstad, Sweden.
  • Gimsing P; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Vangsted AJ; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • Frølund U; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • Holmberg E; Department of Hematology, Zealand University, Roskilde, Denmark.
  • Gahrton G; Department of Hematology, Zealand University, Roskilde, Denmark.
  • Alici E; Department of Oncology, Institute of Clinical Sciences, Gothenburg, Sweden.
  • Hardling M; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Mellqvist UH; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Nahi H; Department of Hematology, Uddevalla Hospital, Uddevalla, Sweden.
Cancer Med ; 7(6): 2256-2268, 2018 06.
Article em En | MEDLINE | ID: mdl-29673108
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dexametasona / Inibidores da Angiogênese / Lenalidomida / Anti-Inflamatórios / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suécia País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dexametasona / Inibidores da Angiogênese / Lenalidomida / Anti-Inflamatórios / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suécia País de publicação: Estados Unidos